Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 14 (MTND1P14) is a **pseudogene** found on human chromosome 17[2][4]. It is a nuclear DNA sequence with significant sequence homology to the mitochondrial gene MT-ND1, which itself encodes a core subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase)[2][4]. Unlike the genuine mitochondrial MT-ND1 gene, MTND1P14 does not produce a functional protein and currently has no known biological or disease-modifying function. It is not a protein-coding gene and therefore not a direct target for therapeutic drugs, not involved in classical molecular pathways, and not considered a biomarker or safety concern. Important clarification: There is nothing inherently "incorrect" about the gene itself, but for the purposes of drug discovery, molecular pharmacology, or biomarker research, a pseudogene like MT-ND1 pseudogene 14 is **not a suitable or recognized therapeutic target**[4]. Most research and therapeutic attention relate to the protein-coding mitochondrial gene MT-ND1; the pseudogene should not be confused with the active mitochondrial gene, which is well-known for its role in electron transfer and mitochondrial diseases[1][3][5][7]. If your query concerns the **functional protein-coding mitochondrial gene** (MT-ND1) and its core subunit, those details are available and include involvement in mitochondrial electron transport, roles in neurodegenerative and metabolic diseases, and established use as a biomarker; but these features **do not apply to the pseudogene** MTND1P14[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 14 (MTND1P14).